Literature DB >> 20650468

Malicious use of pharmaceuticals in children.

Shan Yin1.   

Abstract

OBJECTIVE: To describe malicious administration of pharmaceutical agents to children. STUDY
DESIGN: We performed a retrospective study of all pharmaceutical exposures involving children <7 years old reported to the US National Poison Data System from 2000 to 2008 for which the reason for exposure was coded as "malicious."
RESULTS: A total of 1439 cases met inclusion criteria. The mean number of cases per year was 160 (range, 124 to 189) that showed an increase over time. The median (IQR) age was 2 (1.5) years. Outcome data were available for 1244 (86.4%) patients. Of these exposures, 172 resulted in moderate or major outcomes or death. 9.7% of cases involved >1 exposed substance. The most common reported major pharmaceutical categories were analgesics, stimulants/street drugs, sedatives/hypnotics/antipsychotics, cough and cold preparations, and ethanol. In 51% of cases there was an exposure to at least one sedating agent. There were 18 (1.2%) deaths. Of these, 17 (94%) were exposed to sedating agents, including antihistamines (8 cases) and opioids (8 cases).
CONCLUSIONS: Malicious administration of pharmaceuticals should be considered an important form of child abuse.
Copyright © 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20650468     DOI: 10.1016/j.jpeds.2010.05.040

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  3 in total

1.  Toxico-surveillance of infant and toddler poisonings in the United States.

Authors:  Yaron Finkelstein; Janine R Hutson; Paul M Wax; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2012-09

2.  Acute chemical ingestion in the under 19 population in South Korea: A brief report.

Authors:  Jae Hee Lee; Duk Hee Lee
Journal:  PLoS One       Date:  2020-11-13       Impact factor: 3.240

3.  Pediatric drug overdose mortality: contextual and policy effects for children under 12 years.

Authors:  Brian C Kelly; Mike Vuolo; Laura C Frizzell
Journal:  Pediatr Res       Date:  2021-05-21       Impact factor: 3.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.